+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Spastic Cerebral Palsy Epidemiology Forecast 2025-2034

  • PDF Icon

    Report

  • 150 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 6092340
In children, cerebral palsy (CP) is the most prevalent motor disability. According to recent global population-based studies, the prevalence of cerebral palsy (CP) ranges from 1 to almost 4 cases per 1,000 live births or children. Nearly 61% of all cerebral palsy patients have spastic cerebral palsy, which is still the most prevalent form of the condition.

Spastic Cerebral Palsy Epidemiology Forecast Report Coverage

The “Spastic Cerebral Palsy Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of spastic cerebral palsy. It projects the future incidence and prevalence rates of spastic cerebral palsy across various populations. The study covers age, gender, and type as major determinants of the spastic cerebral palsy-affected population. The report highlights patterns in the prevalence of spastic cerebral palsy over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of spastic cerebral palsy in the 8 major markets.

Regions Covered

  • The United States
  • Germany
  • France
  • Italy
  • Spain
  • The United Kingdom
  • Japan
  • India

Spastic Cerebral Palsy Disease Overview

Spastic cerebral palsy is a neurological disorder that impairs movement and muscle coordination. It is brought on by brain damage that occurs prior to, during, or soon after birth. Exaggerated reflexes, difficulty with voluntary movements, and muscle stiffness (spasticity) are the characteristics of this type of cerebral palsy. Walking, posture, and fine motor skills can all be affected by the condition, which mainly affects the motor cortex and can affect one or more limbs. The severity varies; some people have minor mobility issues, while others have severe mobility impairments.

Spastic Cerebral Palsy: Treatment Overview

The goal of treatment for spastic cerebral palsy is to improve mobility and manage symptoms through a combination of therapies and medical interventions. Occupational and physical therapy improve everyday functioning, flexibility, and muscle control. To reduce spasticity, doctors may prescribe drugs like muscle relaxants (like baclofen or botulinum toxin). In extreme situations, orthopaedic surgery or selective dorsal rhizotomy (SDR) can help with posture and movement. Depending on the needs of everyone, assistive technology, orthotics, and speech therapy may also be included.

Epidemiology

The spastic cerebral palsy epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for spastic cerebral palsy by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for spastic cerebral palsy and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.
  • According to the Cerebral Palsy Alliance Research Foundation (CPARF), spastic cerebral palsy (CP) accounts for 70-80% of all cases of CP, making it the most prevalent type. Extreme muscle tension brought on by this kind of CP can paralyze half of the body, all four limbs, or two limbs.
  • An article addressed that 30% of spastic cerebral palsy cases are unilateral in nature while 69% cases of spastic cerebral palsy are bilateral in nature. The percentage of cases of spastic cerebral palsy that are unaccounted for is 0.7%.
  • According to a study conducted in India, around 32.22% of the children affected by the condition were between the ages of 48 and 96 months, and 67.57% of the children were male. According to the classification, 77.34% of patients had a spastic form of cerebral palsy, with diplegic cerebral palsy being the most prevalent with around 42.83%.
  • According to the Cerebral Palsy Research Network, it is estimated that 1 in 345 Americans suffer from cerebral palsy. Of the children diagnosed with cerebral palsy, the majority (82.9%) had spastic cerebral palsy.

Country-wise Spastic Cerebral Palsy Epidemiology

The spastic cerebral palsy epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of spastic cerebral palsy varies between countries, owing to the differences in factors such as high rates of preterm births, delayed access to neonatal care, poor maternal healthcare, and infections like meningitis, malaria, etc. According to the Centers for Disease Control and Prevention Metropolitan Atlanta Developmental Disabilities Surveillance Program, the first multi-state study examined the prevalence of cerebral palsy in children aged 8 in southeastern Wisconsin, northern Alabama, and metropolitan Atlanta. Analysis was done on 114,897 children's data. There were 3.6 cases of cerebral palsy for every 1,000 children. Accounting for 76.9% of all cases, spastic cerebral palsy was the most prevalent type.

Scope of the Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of Spastic Cerebral Palsy based on several factors.
  • Spastic Cerebral Palsy Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The report helps to identify the patient population, and the unmet needs of Spastic Cerebral Palsy are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

  • What are the key findings of spastic cerebral palsy epidemiology in the 8 major markets?
  • What will be the total number of patients with spastic cerebral palsy across the 8 major markets during the forecast period?
  • What was the country-wise prevalence of spastic cerebral palsy in the 8 major markets in the historical period?
  • Which country will have the highest number of spastic cerebral palsy patients during the forecast period of 2025-2034?
  • Which key factors would influence the shift in the patient population of spastic cerebral palsy during the forecast period of 2025-2034?
  • What are the currently available treatments for spastic cerebral palsy?
  • What are the disease risks, signs, symptoms, and unmet needs of spastic cerebral palsy?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Introduction
1.2 Objectives of the Study
1.3 Research Methodology and Assumptions
2 Executive Summary
3 Spastic Cerebral Palsy Market Overview - 8 MM
3.1 Spastic Cerebral Palsy Market Historical Value (2018-2024)
3.2 Spastic Cerebral Palsy Market Forecast Value (2025-2034)
4 Spastic Cerebral Palsy Epidemiology Overview - 8 MM
4.1 Spastic Cerebral Palsy Epidemiology Scenario (2018-2024)
4.2 Spastic Cerebral Palsy Epidemiology Forecast (2025-2034)
5 Disease Overview
5.1 Signs and Symptoms
5.2 Causes
5.3 Risk Factors
5.4 Guidelines and Stages
5.5 Pathophysiology
5.6 Screening and Diagnosis
5.7 Types of Spastic Cerebral Palsy
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
7 Epidemiology Scenario and Forecast - 8 MM (218-2034)
7.1 Key Findings
7.2 Assumptions and Rationale
7.3 Diagnosed Prevalent Cases of Spastic Cerebral Palsy
7.4 Type-Specific Cases of Spastic Cerebral Palsy
7.5 Gender-Specific Cases of Spastic Cerebral Palsy
7.6 Age-Specific Cases of Spastic Cerebral Palsy
8 Epidemiology Scenario and Forecast: United States (218-2034)
8.1 Assumptions and Rationale in the US
8.2 Diagnosed Prevalent Cases of Spastic Cerebral Palsy in the US
8.3 Type-Specific Cases of Spastic Cerebral Palsy in the US
8.4 Gender-Specific Cases of Spastic Cerebral Palsy in the US
8.5 Age-Specific Cases of Spastic Cerebral Palsy in the US
9 Epidemiology Scenario and Forecast: United Kingdom (218-2034)
9.1 Assumptions and Rationale in United Kingdom
9.2 Diagnosed Prevalent Cases of Spastic Cerebral Palsy in United Kingdom
9.3 Type-Specific Cases of Spastic Cerebral Palsy in United Kingdom
9.4 Gender-Specific Cases of Spastic Cerebral Palsy in United Kingdom
9.5 Age-Specific Cases of Spastic Cerebral Palsy in United Kingdom
10 Epidemiology Scenario and Forecast: Germany (218-2034)
10.1 Assumptions and Rationale in Germany
10.2 Diagnosed Prevalent Cases of Spastic Cerebral Palsy in Germany
10.3 Type-Specific Cases of Spastic Cerebral Palsy in Germany
10.4 Gender-Specific Cases of Spastic Cerebral Palsy in Germany
10.5 Age-Specific Cases of Spastic Cerebral Palsy in Germany
11 Epidemiology Scenario and Forecast: France (218-2034)
11.1 Assumptions and Rationale in France
11.2 Diagnosed Prevalent Cases of Spastic Cerebral Palsy in France
11.3 Type-Specific Cases of Spastic Cerebral Palsy in France
11.4 Gender-Specific Cases of Spastic Cerebral Palsy in France
11.5 Age-Specific Cases of Spastic Cerebral Palsy in France
12 Epidemiology Scenario and Forecast: Italy (218-2034)
12.1 Assumptions and Rationale in Italy
12.2 Diagnosed Prevalent Cases of Spastic Cerebral Palsy in Italy
12.3 Type-Specific Cases of Spastic Cerebral Palsy in Italy
12.4 Gender-Specific Cases of Spastic Cerebral Palsy in Italy
12.5 Age-Specific Cases of Spastic Cerebral Palsy in Italy
13 Epidemiology Scenario and Forecast: Spain (218-2034)
13.1 Assumptions and Rationale in Spain
13.2 Diagnosed Prevalent Cases of Spastic Cerebral Palsy in Spain
13.3 Type-Specific Cases of Spastic Cerebral Palsy in Spain
13.4 Gender-Specific Cases of Spastic Cerebral Palsy in Spain
13.5 Age-Specific Cases of Spastic Cerebral Palsy in Spain
14 Epidemiology Scenario and Forecast: Japan (218-2034)
14.1 Assumptions and Rationale in Japan
14.2 Diagnosed Prevalent Cases of Spastic Cerebral Palsy in Japan
14.3 Type-Specific Cases of Spastic Cerebral Palsy in Japan
14.4 Gender-Specific Cases of Spastic Cerebral Palsy in Japan
14.5 Age-Specific Cases of Spastic Cerebral Palsy in Japan
15 Epidemiology Scenario and Forecast: India (218-2034)
15.1 Assumptions and Rationale in India
15.2 Diagnosed Prevalent Cases of Spastic Cerebral Palsy in India
15.3 Type-Specific Cases of Spastic Cerebral Palsy in India
15.4 Gender-Specific Cases of Spastic Cerebral Palsy in India
15.5 Age-Specific Cases of Spastic Cerebral Palsy in India
16 Patient Journey17 Treatment Challenges and Unmet Needs18 Key Opinion Leaders (KOL) Insights